Acme United Q2 net sales rise 16% to $62.7 million; net income up 6%
Acme United reported second-quarter 2026 net sales of $62.7 million, up 16% from $54.0 million a year earlier, and net income of $5.1 million, or $1.22 per diluted share, versus $1.16 a year earlier. Excluding sales from the My Medic acquisition, comparable quarterly sales rose 8%, and the company said My Medic had minimal impact on second-quarter earnings. For the six months, net income fell 6% to $6.0 million and diluted EPS fell 7% to $1.46, which the company attributed mainly to first-quarter results.
Key points
- Q2 2026 net sales were $62.7 million versus $54.0 million, up 16%; excluding My Medic, up 8%.
- Q2 2026 net income was $5.1 million, or $1.22 per diluted share, versus $4.8 million, or $1.16, a year earlier.
- Six-month net income was $6.0 million, or $1.46 per diluted share, down 6% and 7% respectively from the same period in 2025.
- On July 15, 2026, the company entered into a new $65 million syndicated credit facility expiring July 15, 2029.
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 23, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.